#Market News January 22, 2018 / 11:45 AM / in 9 hours BRIEF-Chromadex - Patent Trial And Appeal Board Of U.S. Patent And Trademark Office Denied Elysium Health's Request To Invalidate U.S. Patent Reuters Staff 1 Min Read 
Jan 22 (Reuters) - Chromadex Corp: 
* CHROMADEX - PATENT TRIAL AND APPEAL BOARD OF U.S. PATENT AND TRADEMARK OFFICE DENIED ELYSIUM HEALTH INC.â€˜S REQUEST TO INVALIDATE U.S. PATENT 
* CHROMADEX - U.S. PATENT COVERING COMPOSITIONS COMPRISING NICOTINAMIDE RIBOSIDE, WHICH CHROMADEX CURRENTLY LICENSES FROM TRUSTEES OF DARTMOUTH COLLEGE Source text for Eikon: Further company coverage: